English (UK)Português (BR)
Entrar

Acesse sua conta de usuário

Nome de usuário *
Senha *
Lembrar de mim
Imprimir

Ana Marisa Chudzinski-Tavassi

A MARISA Ana Marisa Chudzinski Tavassi

Nome científico: Chudzinski-Tavassi AM
Posição: Pesquisadora Associada; Pesquisador Científico-VI e Diretora do Laboratório de Bioquímica e Biofísica / Instituto Butantan


 
lattes Currículo Lattes
CONTATO
 
phoneFone
+55 11 2627-9738
email E-mail
O endereço de e-mail address está sendo protegido de spambots. Você precisa ativar o JavaScript enabled para vê-lo.  
info Unidade
Instituto Butantan > Laboratório de Bioquímica e Biofísica
enderecoEndereço
Instituto Butantan
Laboratório de Bioquímica e Biofísica
Av. Vital Brasil, 1500
CEP 05503-900 São Paulo, SP - Brasil

 

Publicações

2017

Ibal A, Goldfeder MB, Marques-Porto R, Asif H, Souza JG, Faria F, Chudzinski-Tavassi AM. Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin. Sci Rep. 3;7(1):1431 (2017).

Bosch RV, Alvarez-Flores MP, Maria DA, Chudzinski-Tavassi AM. Hemolin triggers cell survival on fibroblasts in response to serum deprivation by inhibition of apoptosis. Biomedicine & Pharmacotherapy 82: 537-546 (2016).

Branco VG, Iqbal A, Alvarez-Flores MP, Sciani JM, de Andrade SA, Iwai LK, Serrano SM, Chudzinski-Tavassi AM. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo. Biochim Biophys Acta. 1864(10):1428-35 (2016).

Carlstron JP, Verreschi DC, Batista IDC, Tsubouchi BD, de Abreu BCG, Mastantuno D, Ito DT, Ramos PW, Szczygiel NL, Chudzinski-Tavassi AM, Cruz JÁ, Barazzone GC, de Andrade AS. Segregation and packaging of Chemical Products: Deploying a Secure System in the Protein Chemistry Facility of the Laboratory of Biochemistry and Biophysics - Butantan Institute. Orbital-Electronic Journal Of Chemistry v. 8 Ed. 3 p. 218-225 (2016).

Chudzinski-Tavassi AM, Morais KL, Pacheco MT, Pasqualoto KFM, de Souza JG. Tick salivary gland as potential natural source for the discovery of promising antitumor drug candidates. Biomed Pharmacother 77:14-9. (2016). Review.

de Souza JG, Morais KL, Anglés-Cano E, Boufleur P, de Mello ES, Maria DA, Origassa CS, de Campos Zampolli H, Câmara NO, Berra CM, Bosch RV, Chudzinski-Tavassi AM.Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model. Oncotarget. 20;7(38):62255-62266 (2016).

Morais KL, Pacheco MT, Berra CM, Bosch RV, Sciani JM, Chammas R, de Freitas Saito R, Iqbal A, Chudzinski-Tavassi AM. Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell. Mol Cell Biochem 415(1-2):119-31 (2016).

Pacheco MT, Morais KL, Berra CM, Demasi M, Sciani JM, Branco VG, Bosch RV, Iqbal A, Chudzinski-Tavassi AM. Specific role of cytoplasmic dynein in the mechanism of action of na antitumor molecule, Amblyomin-X. Exp Cell Res.15;340(2):248-58 (2016).

Pasqualoto KF, Balan A, Barreto SA, Simons SM, Chudzinski-Tavassi AM. Structural findings and molecular modeling approach of a TFPI-like inhibitor. Protein and peptide letters 21(5), 452-457 (2014).

Pavon LF, Sibov TT, de Oliveira DM, Marti LC, Cabral FR, de Souza JG, Boufleur P, Malheiros SMF, Neto MAD, da Cruz EF, Chudzinski-Tavassi AM, Cavalheiro S. Mesenchymal stem cell-like properties of CD133(+) glioblastoma-initiating cells. Oncotarget v. 7. 40546-40557 (2016).

Sato AC, Bosch RV, Will SE, Alvarez-Flores MP, Goldfeder MB, Pasqualoto KF, da Silva BA, de Andrade SA, Chudzinski-Tavassi AM. Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar Lonomia obliqua. J Venom Anim Toxins Incl Trop Dis. 21;22:36 (2016).

Zambelli VO, Pasqualoto KF, Picolo G, Chudzinski-Tavassi AM, Cury Y. Harnessing the knowledge of animal toxins to generate drugs. Pharmacol Res. pii: S1043- 6618(16)00015-3. (2016). Review.

2015

Amorim A, Prado MX, De Oliveira UC, Faria F, Pasqualoto KFM, Junqueira-De-Azevedo ILM, Chudzinski-Tavassi AM. Transcripts involved in hemostasis: Exploring salivar complexes from Haementeria vizottoi leeches through transcriptomics, phylogenetic studies and structural features. Toxicon (Oxford), 106, p. 20-29 (2015).

Chudzinski-Tavassi AM, Picolo G, Pasqualoto KFM, Cury Y. Vital Brasil e o pioneirismo na utilização de venenos animais como agentes terapêuticos. Cadernos de História da Ciência, v. 10, p. 13-32 (2015).

Drewes CC, Dias RY, Branco VG, Cavalcante MF, Souza JG, Abdalla DS, Chudzinski-Tavassi AM, Farsky SH. Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endotelial cells. Toxicon 101:1-10 (2015).

Iqbal A, Goldfeder MB, Marques-Porto R, Asif H, Souza JG, Faria F, Chudzinski-Tavassi AM. Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin. Sci Rep. 3;7(1):1431 (2017).

2014

Chudzinski-Tavassi AM, Carvalho LCC, Alvarez-Flores MP, Andrade SA.Exogenous procoagulant factors as therapeutic and biotechnological tools.  J Blood Disorders Transf. 2014 ; 5:209.

Pasqualoto KF, Balan A, Barreto SA, Simons SM, Chudzinski-Tavassi AM.Structural characterization of the cell division cycle in Strigomonas culicis, an endosymbiont-bearing trypanosomatid. Protein Pept Lett. 2014 May;21(5):452-7.

Pasqualoto KF, Balan A, Barreto SA, Simons SM, Chudzinski-Tavassi AM. Structural findings and molecular modeling approach of a TFPI-like inhibitor. Protein and peptide letters 21(5), 452-457 (2014).

Wlian L, Carrijo-Carvalho LC, Andrade AS, Lorenco SV, Rodrigues CJ, Maria DA, Chudzinski-Tavassi AM. Wound Healing Effects of a Lipocalin-Derived Peptide. J Clin Toxicol. 2014; 4:187.

2013

Mafra CS, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Taguchi FM, Foronda AS, Carvalho FR, de Freitas D. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity. Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6363-72.

Maria DA, de Souza JG, Morais KL, Berra CM, Zampolli H de C, Demasi M, Simons SM, de Freitas Saito R, Chammas R, Chudzinski-Tavassi AM.A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production.  Invest New Drugs. 2013 Jun;31(3):493-505.

Mesquita Pasqualoto KF, Carrijo-Carvalho LC, Chudzinski-Tavassi AM. Rational development of novel leads from animal secretion based on coagulation and cell targets: 1. In silico analysis to explore a peptide derivative as lipocalins’ signature. Toxicon. 2013 Jul; 69:200-10.

Morais KL, Mesquita Pasqualoto KF, Pacheco MTF, Berra CM, Alvarez-Flores MP, Chudzinski-Tavassi AM. Rational development of a novel TFPI-like inhibitor from Amblyomma cajennense tick.  Toxin Reviews. 2013 ;33:1-

Ventura JS, Faria F, Batista IF, Simons SM, Oliveira DG, Morais KL, Chudzinski-Tavassi AM. A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis. Biomed Pharmacother. 2013 Apr;67(3):192-6.

Vieira ML, Alvarez-Flores MP, Kirchgatter K, Romero EC, Alves IJ, de Morais ZM, Vasconcellos SA, Chudzinski-Tavassi AM, Nascimento AL. Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels. Infect Immun. May;81(5):1764-74 (2013)

ZM, Vasconcellos SA, Chudzinski-Tavassi AM, Nascimento AL. Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.  Infect Immun. 2013 May;81(5):1764-74.

 

 

 

 

O endereço de e-mail address está sendo protegido de spambots. Você precisa ativar o JavaScript enabled para vê-lo.

logo-fapesp